Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Lead-in Cohort • To assess the safety and tolerability of PF-04449913 in patients with primary or secondary MF who have been previously treated with ≥1 JAKi. Randomized Cohort • To compare the effect of PF-04449913 vs. placebo on SVR in patients with primary or secondary MF who have been previously treated with ruxolitinib.
Inclusion criteria
- Myelofibrosis